Biphasic Papillary and Lobular Breast Carcinoma With PIK3CA and IDH1 Mutations.
Diagn. Mol. Pathol., Dec;21(4):221-4 (2012)
Human pancreatic cancer fusion 2 (HPC2) 1-B3: A novel monoclonal antibody to screen for pancreatic ductal dysplasia.
Cancer Cytopathol., Jul (2012)
Loss of succinate dehydrogenase subunit B (SDHB) expression is limited to a distinctive subset of gastric wild-type gastrointestinal stromal tumours: a comprehensive genotype-phenotype correlation study.
Histopathology., Nov;61(5):801-9 (2012)
Mucinous breast carcinomas lack PIK3CA and AKT1 mutations.
Hum. Pathol., Dec;43(12):2207-12 (2012)
Multiplex high-throughput gene mutation analysis in acute myeloid leukemia.
Hum. Pathol., Dec;43(12):2167-76 (2012)
Efficacy and safety of regorafenib in patients with metastatic and/or unresectable GI stromal tumor after failure of imatinib and sunitinib: a multicenter phase II trial.
J. Clin. Oncol., Jul;30(19):2401-7 (2012)
Tackling formalin-fixed, paraffin-embedded tumor tissue with next-generation sequencing.
Cancer Discov., Jan;2(1):23-4 (2012)
Phosphatidylinositol-3-kinase pathway mutations are common in breast columnar cell lesions.
Mod. Pathol., Jul;25(7):930-7 (2012)
The novel monoclonal antibody HPC2 and N-cadherin distinguish pancreatic ductal adenocarcinoma from cholangiocarcinoma.
Hum. Pathol., Oct;43(10):1583-9 (2012)
BRAF and KRAS mutations in sporadic glomus tumors.
Am J Dermatopathol., Jul;34(5):533-5 (2012)
Medicine. Personalized cancer diagnostics.
Science., Dec;334(6060):1217-8 (2011)
Gastrointestinal stromal tumours: origin and molecular oncology.
Nat. Rev. Cancer., Dec;11(12):865-78 (2011)
S0356: a phase II clinical and prospective molecular trial with oxaliplatin, fluorouracil, and external-beam radiation therapy before surgery for patients with esophageal adenocarcinoma.
J. Clin. Oncol., Dec;29(34):4555-60 (2011)
A DNA methylation microarray-based study identifies ERG as a gene commonly methylated in prostate cancer.
Epigenetics., Oct;6(10):1248-56 (2011)
Multiplex mutation screening by mass spectrometry evaluation of 820 cases from a personalized cancer medicine registry.
J Mol Diagn., Sep;13(5):504-13 (2011)
Phase II, open-label, single-arm trial of imatinib mesylate in patients with metastatic melanoma harboring c-Kit mutation or amplification.
J. Clin. Oncol., Jul;29(21):2904-9 (2011)
Novel biomarker candidates to predict hepatic fibrosis in hepatitis C identified by serum proteomics.
Dig. Dis. Sci., Nov;56(11):3305-15 (2011)
Primary melanoma of the spinal cord: a case report, molecular footprint, and review of the literature.
J. Clin. Oncol., Jun;29(17):e499-502 (2011)
Hypoxia-induced inflammatory cytokine secretion in human adipose tissue stromovascular cells.
Diabetologia., Jun;54(6):1480-90 (2011)
"Pediatric-type" gastrointestinal stromal tumors in adults: distinctive histology predicts genotype and clinical behavior.
Am. J. Surg. Pathol., Apr;35(4):495-504 (2011)